Design Therapeutics DSGN
NASDAQ DSGN
$15.14 +0.11 (+0.73%)
As of: Sep 4, 2026 · 3:59 PM EDT

Design Therapeutics (DSGN) Property, Plant & Equipment (Net) (2020 - 2026)

Analysis

Design Therapeutics (DSGN) Property, Plant & Equipment (Net) (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.06 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 34.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.64 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 554.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 107.22 Mn
10 Design Therapeutics 945.71 Mn 738.31 Mn - 694,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 694,000.00
Mar 31, 2026 824,000.00
Dec 31, 2025 981,000.00
Sep 30, 2025 1.10 Mn
Jun 30, 2025 1.26 Mn
Mar 31, 2025 1.38 Mn
Dec 31, 2024 1.41 Mn
Sep 30, 2024 1.56 Mn
Jun 30, 2024 1.73 Mn
Mar 31, 2024 1.72 Mn
Dec 31, 2023 1.69 Mn
Sep 30, 2023 1.78 Mn
Jun 30, 2023 1.86 Mn
Mar 31, 2023 1.91 Mn
Dec 31, 2022 1.95 Mn
Sep 30, 2022 1.84 Mn
Jun 30, 2022 1.80 Mn
Mar 31, 2022 1.45 Mn
Dec 31, 2021 1.51 Mn
Sep 30, 2021 1.32 Mn